Clinical Trials Logo
  1. Home
  2. Metabolic Disorder
  3. NCT02650674

Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products

Metabolic Disorder Clinical Trial

Official title:
Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products

Clinical Trial Summary

This study aimed at determining the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products in two different ethnic groups.

Clinical Trial Description

This study aimed at determining the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products in two different ethnic groups. It is a laboratory-based research study, conducted in two different ethnic groups, with an open cross-over design, including 24 healthy non-smoking voluntary subjects, aged from 18 to 45 years. 12 subjects will be Caucasian and 12 subjects will be Asian. 8 test sessions per subject are included in the study. Foods are consumed in a random order according to a randomisation list. The impact of the ethnic group and the products will be determined. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02650674
Study type Interventional
Source Mondelez International, Inc.
Contact
Status Completed
Phase N/A
Start date October 2015
Completion date April 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00546052 - A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) Phase 3
Completed NCT00707746 - Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects Phase 2
Completed NCT02573103 - Air Pollution and Cardiovascular Disease
Not yet recruiting NCT06051461 - Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication N/A
Not yet recruiting NCT05013112 - Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT) N/A
Enrolling by invitation NCT04654000 - Rheopheresis as Adjuvant Treatment of Calciphylaxis N/A
Completed NCT01337141 - A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients N/A
Completed NCT00477594 - Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia Phase 2
Recruiting NCT03882580 - Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Active, not recruiting NCT01911091 - Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus) N/A
Completed NCT00607373 - Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia Phase 3
Completed NCT00362180 - Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration Phase 2
Completed NCT03873948 - Evaluation of Arginine in Periodontal and Cardiovascular Disease
Completed NCT01738061 - A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan N/A
Completed NCT02059993 - The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease N/A
Completed NCT06129578 - Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals N/A
Completed NCT06331572 - Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
Completed NCT05255718 - Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome N/A
Completed NCT00694109 - An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia Phase 3